Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Chimeric Therapeutics Ltd. is offering up to 625 million shares and the same number of options to raise up to $5 million, with shares priced at $0.008 each. This move includes a significant contribution from Executive Chairman Paul Hopper, highlighting the company’s commitment to growth. Investors should note the speculative nature of this offer.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.